We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Silence Therapeutics Plc | LSE:SLN | London | Ordinary Share | GB00B9GTXM62 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 535.00 | 521.00 | 524.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMSLN
RNS Number : 2264I
Silence Therapeutics PLC
31 March 2020
TR-1: S tandard form for notification of major holdings
Hot Features
Premium
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the Silence Therapeutics Plc
underlying issuer of existing shares
to which voting rights are attached
(ii) :
--------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights - Dilution on placing X
of shares
----
Other (please specify)(iii) :
----
3. Details of person subject to the notification obligation (iv)
Name Richard Griffiths and controlled
undertakings
City and country of registered office St Helier, Jersey
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name
--------------------------------------------
City and country of registered office
(if applicable)
--------------------------------------------
5. Date on which the threshold was 30 March 2020
crossed or reached (vi) :
--------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 30 March 2020
--------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer (vii)
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ --------------------- -------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 27.94% 0.00% 27.94% 82,646,845
------------------ --------------------- -------------- --------------------
Position of
previous notification
(if
applicable) 21.81% 7.30% 29.11%
------------------ --------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
-----------------------
GB00B9GTXM62 23,091,519 0 27.94% 0.00%
---------------------- ----------------------- ----------------------------- --------------------------
SUBTOTAL 8. A 23,091,519 27.94%
----------------------------------------------- ---------------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
(x) (xi) be acquired if
the instrument
is
exercised/converted.
------------ ----------------------- --------------------------------------- --------------------------
SUBTOTAL 8. B 1
----------------------- --------------------------------------- --------------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical Number of % of voting
financial date (x) Conversion Period or cash voting rights rights
instrument (xi) settlement
(xii)
------------------ ----------------------- --------------------- ----------------
SUBTOTAL
8.B.2
--------------------- ----------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any
other undertaking(s) holding directly or indirectly an interest
in the (underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting X
rights and/or the
financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity (xiv) (please
add additional rows as necessary)
Name (xv) % of voting rights % of voting rights Total of both
if it equals through financial if it equals
or is higher instruments if or is higher
than the notifiable it equals or is than the notifiable
threshold higher than the threshold
notifiable threshold
----------------------- ----------------------------------- ---------------------------
Blake Holdings Limited 10.38% 10.38%
----------------------- ----------------------------------- ---------------------------
Serendipity Capital Limited 11.27% 11.27%
----------------------- ----------------------------------- ---------------------------
Sarossa Plc 2.67% 2.67%
----------------------- ----------------------------------- ---------------------------
Oak Trust Limited 0.33% 0.33%
----------------------- ----------------------------------- ---------------------------
Richard Griffiths 2.45% 2.45%
----------------------- ----------------------------------- ---------------------------
Cream Capital Limited 0.84% 0.84%
----------------------- ----------------------------------- ---------------------------
Total 27.94% 27.94%
----------------------- ----------------------------------- ---------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder N/A
----------------------------------------------------------------
The number and % of voting rights held N/A
----------------------------------------------------------------
The date until which the voting rights N/A
will be held
----------------------------------------------------------------
11. Additional information (xvi)
Place of completion St Helier, Jersey, Channel Islands
Date of completion 30 March 2020
-----------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLUAVRRRRUOOAR
(END) Dow Jones Newswires
March 31, 2020 06:51 ET (10:51 GMT)
1 Year Silence Therapeutics Chart |
1 Month Silence Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
